Company ProfilePremium

RENHENG Enterprise Holdings Limited

Company Profile Analysis

Ticker: 3628.HK仁恒實業控股有限公司

ESOMAR 23 Corporate BadgeISO Certifications Badge
RENHENG Enterprise Holdings Limited - Company showcase

Year Founded & Workforce

2002

138 Employees

RENHENG Enterprise Holdings Limited logo

RENHENG Enterprise Holdings Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

RENHENG Enterprise Holdings Limited Overview

RENHENG is a micro-cap, single-segment, China-only manufacturer of special-purpose tobacco primary-processing machinery, operating through its wholly owned Jiangsu subsidiary Baoying Renheng. It holds a Tobacco Monopoly Production Enterprise Licence issued by the State Tobacco Monopoly Administration and describes itself as one of 35 licensed manufacturers in the PRC — a regulatory moat that restricts entry into a market whose end customers are the cigarette factories and leaf redrying plants of the state tobacco monopoly. Revenue is dominated by project-based, customised "casing and flavouring systems" (80–95% of sales in recent periods), supplemented by pneumatic feeding systems and occasional pre-pressing packing machines. The business is lumpy, tender-driven and highly customer-concentrated (top five customers 75.7% of FY2025 sales). It carries no debt and a net cash position of roughly HK$105–123M against a market value of about HK$160M, but faces sharp bid-price compression in 2026 and a long-stated, still-unrealised ambition to diversify into non-tobacco automation.


What the company does

RENHENG's listed holding company is an investment holding vehicle that also provides corporate management services; substantially all operations sit in Baoying Renheng, located in Baoying County, Jiangsu Province (AR2025, Report of Directors and ESG Report). The Group manufactures, sells, and provides maintenance, overhaul and modification services for tobacco machinery products in the PRC. Its licence from the State Tobacco Monopoly Administration permits it to manufacture, sell and service catalogued special-purpose tobacco machinery (AR2025 MD&A).

The company's own description (paraphrased from AR2025 and IR 1H2026)

Management describes the Group as generating turnover mainly from projects involving catalogued special-purpose tobacco machinery — chiefly the casing and flavouring system and the pneumatic feeding system, with the 1H2026 interim report also listing the pre-pressing packing machine as a third principal product type. Management characterises its principal customer as the "Tobacco Monopoly Administration of the PRC" (in practice, the provincial China Tobacco industrial companies and their cigarette factories and redrying plants), asserts that the domestic tobacco machinery industry should see steady momentum because cigarette makers continually replace machines with more technologically advanced equipment, and states an intention to use its customisation and development capabilities to win non-standard automated machinery contracts in other industries.

Business model and revenue model

DimensionCharacterisationEvidence
Revenue typePredominantly project/product revenue; no subscription or licensing revenue disclosedRA2025 Note 4
Product vs. service mixProduct/project revenue ~100% of reported revenue; maintenance/overhaul/modification services are part of the licensed scope but not separately reportedRA2025 Note 4
Revenue recognitionPoint in time for all streams. Casing and flavouring systems recognised when the completed system transfers to the customer (no enforceable right to payment before transfer); other products on deliveryRA2025 Note 4(ii)
Customer prepayments10%–30% of contract value received as deposit on signing, creating contract liabilities throughout constructionRA2025 Note 4(ii), Note 13
Credit termsNormally 90 days upon delivery / three monthsRA2025 Note 4(ii), Note 11
WarrantyDefect liability period of one to three years (FY2025 AR/RA); one to two years stated in IR 1H2026RA2025; IR 1H2026
Contract pricingFixed-price, customer-specified, non-standard customised equipment; won through biddingRA2025; IR 1H2026
ProcurementProject-specific procurement after contract signing, from an approved-supplier list reviewed annually; 946 suppliers in FY2025, 807 in Eastern ChinaAR2025 ESG Report B5

Value-chain position

RENHENG sits in the equipment tier of the Chinese tobacco value chain, supplying the "primary processing" (制丝) stage of cigarette manufacturing — the cut-tobacco preparation process in which leaf is conditioned, cased (moistened with casing liquid), cut, dried, flavoured and conveyed to cigarette-making machines. Pre-pressing packing machines serve leaf redrying factories upstream. It does not make cigarette-making or packing machines (the "secondary processing" stage). Its customers are state-owned enterprises within the China National Tobacco monopoly system; it also received "Excellent Supplier" recognition in 2022 and 2023 from Qinhuangdao Tobacco Machinery Co., Ltd., a company controlled by China Tobacco Machinery Group (RA2023 MD&A), indicating that it also supplies or subcontracts to the state-owned tobacco machinery group itself.

Customer types and end-markets

Customer typeProducts soldSource
Cigarette manufacturers (provincial China Tobacco industrial companies' factories)Casing and flavouring systems; pneumatic feeding systems; other goodsRA2025 Note 4(ii)
Tobacco leaf redrying factoriesPneumatic feeding systems; pre-pressing packing machines; other goodsRA2025 Note 4(ii)
Tobacco machinery group companies (e.g., Qinhuangdao Tobacco Machinery)Not specified; supplier award disclosedRA2023 MD&A

End-market: 100% PRC tobacco industry in every year FY2021–FY2025 and 1H2026 (RA2025 Note 4; IR 1H2026 Note 4). The ESG report also references inspection specifications for water treatment equipment products, consistent with small historical water-treatment sales (AR2025 ESG B6; RA2023).

Independent characterisation

RENHENG is best understood as a licensed niche contractor to a single state monopoly. Its economics are governed by three variables: (i) the number and size of factory upgrade projects tendered by China Tobacco's provincial companies; (ii) bid pricing, which in 1H2026 collapsed as competition among bidders intensified and client budgets were cut (IR 1H2026); and (iii) the timing of customer acceptance, because revenue is recognised only on completion and transfer. The licence restricts new entry but does not protect price. The Group's real competitive assets are its licence, its installed base and relationships, and a debt-free balance sheet; its weaknesses are scale (138 employees), extreme concentration, and an unrealised diversification agenda that has appeared in substantially similar wording in every annual report since at least FY2023.

Strategy

Stated strategy (themes from AR2025, RA2025 and IR 1H2026, paraphrased)

  1. Defend the licensed tobacco machinery franchise. Management repeatedly frames its status as one of 35 licensed manufacturers and a supplier to the tobacco monopoly as a stable financial foundation, relying on cigarette factories' continued replacement of machinery with more technologically advanced equipment.

  2. Diversify the revenue structure. Both within tobacco (additional product types) and outside it, by offering non-standardised automatic machinery to other industries that need customised automation, leveraging product customisation, development capability and brand.

  3. Innovate in key technologies for customised automated machinery. R&D spending rose 45.4% in FY2025, attributed to strengthening product functions and establishing new product lines in other industries (RA2025).

  4. Internal management and digitalisation (new in IR 1H2026). Strengthening internal controls and deploying internal digital management systems — including paperless design software and an upgraded integrated project-management platform — to stabilise existing operations and accelerate new business in "new-technological fields".

  5. Conservative capital structure. Maintaining no borrowings and a large cash buffer as insulation against volatility (RA2022 MD&A theme, maintained since).

Initiatives in the last 24 months

InitiativeDate disclosedStatus / quantificationSource
R&D increase towards new product lines in other industries30 Mar 2026FY2025 R&D HK$6.696M (+45.4%); no named non-tobacco product or revenue disclosedRA2025
Increased business promotion, advertising and tender consultancy30 Mar 2026FY2025 selling expenses +HK$3.8M to HK$10.2MRA2025
Digital management systems (paperless design software, integrated project-management platform upgrade)27 Aug 2026No budget disclosedIR 1H2026
Climate-related resource-efficiency programme28 Apr 2026Management expects continued technological innovation and digitalisation to save 1%–2% of total operating costs annually over the next three yearsAR2025 ESG Part D
Energy-efficient/eco-friendly products28 Apr 2026Management expects revenue share of related new products to rise from below 5% to 10%–15% within three yearsAR2025 ESG Part D
Governance modernisation (new articles for hybrid meetings and electronic communications)Mar 2026 (proposal); approved at 25 Jun 2026 AGM per vendor summariesAdministrativeTipRanks summaries of HKEX announcements
Board refresh (Big Four audit partner as INED)31 Oct 2025CompletedHKEX announcement

Medium-term targets and guidance

The Company does not publish revenue, margin or earnings guidance, investor-day targets or capital-return targets. The only forward-looking quantified statements are the climate-section expectations above (1%–2% annual operating-cost savings; 10%–15% revenue share from energy-efficient products within three years), which are indicative rather than formal guidance. The profit warning of 19 August 2026 is the most recent formal forward-looking disclosure, and it related only to the completed half-year.

Products & Services

All products sit within the single tobacco machinery segment. Pricing is contract-specific and determined through bids; list prices are not publicly disclosed. Launch years and detailed technical specifications are not disclosed in the annual reports; descriptions below are based on filings and standard functional definitions of the equipment category.

Casing and flavouring system (加料加香系統) — flagship

AttributeDetail
DescriptionCustomised process systems used in the cut-tobacco primary processing line to apply casing liquids and flavourings to tobacco leaf/strips and cut filler under controlled ratios, moisture and temperature
Commercial formConstruction contracts; fixed price; customer-specified design with no alternative use; delivered, installed and accepted on site
Target customerCigarette factories of provincial China Tobacco industrial companies
Revenue FY2025HK$86.375M (80.4% of revenue); 1H2026 HK$96.306M (95.4%)
Gross margin32.9%–47.8% annually FY2021–FY2025; collapsed to 24.8% in 1H2026 from 45.8% in 1H2025
Contract economics10%–30% deposit; 1–3 year defect liability; retention money receivables held by customers (HK$8.4M gross at end-2025)
Order visibility proxyContract liabilities for casing and flavouring systems: HK$70.5M (end-2021), HK$68.3M (end-2022), HK$45.1M (end-2023), HK$47.5M (end-2024), HK$95.5M (end-2025)
Launch / latest version—
SourcesRA2022–RA2025 Notes 4 and 13; IR 1H2026

Pneumatic feeding system (風力送絲系統)

AttributeDetail
DescriptionAir-conveying systems that transport cut tobacco from storage/blending to cigarette-making machines; the AR2025 climate disclosure refers to a "Pneumatic Silk Conveying System"
Commercial formProduct sale recognised on delivery; 90-day credit
Target customerCigarette manufacturers and redrying factories
RevenueFY2021 HK$14.5M; FY2022 HK$9.9M; FY2023 HK$18.8M; FY2024 HK$3.5M; FY2025 HK$18.4M; 1H2026 HK$3.8M
Gross marginConsistently the highest-margin line (approx. 46%–56% annually)
Strategic noteManagement attributes part of FY2025's profit rise to this line's mix increase to 17.1%
Launch / latest version—

Pre-pressing packing machine (預壓打包機)

AttributeDetail
DescriptionMachinery used at leaf redrying plants to pre-press and pack redried tobacco into cases/bales
RevenueFY2021 HK$15.4M (20.9% of sales); nil FY2022–FY2024; FY2025 HK$2.0M
Gross marginFY2025 approx. 19.4% (HK$0.396M gross profit)
StatusRe-listed by management as one of three principal products in IR 1H2026

Water treatment systems

AttributeDetail
DescriptionSmall water treatment equipment sales; the Group maintains an inspection specification for water treatment equipment manufacturing
RevenueFY2021 HK$0.69M; FY2022 HK$0.71M; FY2023 HK$0.27M; not separately reported FY2024–FY2025
SourcesRA2022; RA2023; AR2025 ESG B6

Other goods

Spare parts, components and miscellaneous goods: HK$5.8M (FY2021), HK$2.9M (FY2022), HK$2.5M (FY2023), HK$2.7M (FY2024), HK$0.6M (FY2025), HK$0.9M (1H2026). Separately, sales of scrap materials, parts and components are booked in other gains (HK$1.267M in FY2025).

Additional equipment referenced by data vendors

Third-party profiles (Simply Wall St, TipRanks) list dedusting systems and swelling-agent delivery systems among the Group's offerings. These are not separately reported in the filings reviewed and are presumably included in "other goods" or within system contracts.

Services

Maintenance, overhaul and modification services for tobacco machinery are within the licensed scope (AR2025 MD&A) but are not reported as a separate revenue stream.

Financial Narrative

All figures HK$ millions unless stated. Sources: RA2022 (FY2021–FY2022), RA2023 (FY2023), RA2025 (FY2024–FY2025).

Income statement

No dilutive instruments existed in any year; diluted EPS equals basic. EBITDA is therefore marked "not publicly disclosed" for formal purposes.

Margin analysis

Revenue CAGR FY2021–FY2025 (four compounding years): approx. 9.9% (analyst-computed: 107.422 / 73.731 = 1.457x). The FY2022 effective tax rate is not meaningful (tax charge on a pre-tax loss, driven by PRC withholding tax and deferred tax).

Commentary. The five-year record shows a fixed-cost structure (selling plus administrative plus R&D of roughly HK$29–38M) that only becomes profitable when revenue exceeds roughly HK$90–100M at historical gross margins. FY2021–FY2022 revenue of ~HK$70M produced operating losses; FY2023's 80% revenue jump produced operating leverage to an 11.7% operating margin. FY2025 is the anomaly: revenue fell 6.5% but gross margin jumped 14.4 points to 47.9%, which management attributes to project-pricing variations from quotation strategies and bid types on non-standard equipment, plus the mix shift towards pneumatic feeding systems (RA2025 MD&A). A HK$2.8M reversal of inventory allowance (versus a HK$1.1M charge in FY2024) also flattered FY2025 cost of sales. The 1H2026 interim then reversed the margin gain: gross margin fell to 26.3% on what management describes as a significant drop in contracted selling prices due to bidder competition and lower client budgets (IR 1H2026). Investors should therefore treat FY2025 margins as a peak rather than a new baseline.

Tax: Baoying Renheng is taxed at 15% as an HNTE; additional PRC withholding tax on undistributed profits (HK$1.199M in FY2025) raises the effective rate. Hong Kong has no assessable profit.

Balance sheet

Notes: Accrued warranty provision was included within trade and other payables in FY2021–FY2023 (HK$3.289M, HK$3.273M, HK$5.406M respectively; RA2022, RA2023). Net debt is negative in every year (net cash). The FY2025 MD&A figure of HK$96.273M for "fixed deposits, FVTPL and cash" excludes pledged deposits.

Commentary. The balance sheet is liquidity-rich and debt-free, but a large part of current assets is contract work-in-progress funded by customer deposits. At end-2025, inventories of HK$105.4M (of which work-in-progress HK$102.7M; IR 1H2026 Note 11) were roughly matched by contract liabilities of HK$100.2M — the classic profile of a project contractor carrying a heavy backlog of uncompleted jobs. Receivables quality deteriorated in FY2024–FY2025: trade receivables past due more than 90 days rose to HK$22.0M at end-2025 (HK$27.2M at end-2024) from HK$1.5M at end-2023 (RA2023; RA2025), coinciding with a change in the ageing basis from invoice date to completion date. At 30 June 2026, only HK$1.7M of net trade receivables of HK$53.4M were aged 0–90 days (IR 1H2026), which merits monitoring despite the state-owned credit quality of the customers. Retained earnings have been negative (accumulated losses of HK$10.7M at end-2021 and HK$13.3M at end-2022; RA2022), and the Company reported no reserves available for distribution at end-2025 (AR2025), a technical constraint on dividends at the holding-company level.

Cash flow

FY2025 operating cash flow, capital expenditure and free cash flow: not publicly disclosed in sources retrieved. Indirect evidence: gross liquid funds (cash, fixed and pledged deposits, FVTPL) rose by HK$7.1M in FY2025 (HK$116.5M to HK$123.5M), including the effect of RMB appreciation on translation, with no dividends, buybacks or debt movements. Capital expenditure is evidently minimal: PPE declined from HK$23.0M (end-2022) to HK$17.8M (end-2025), implying additions below depreciation. No buybacks occurred FY2021–FY2025 or in 1H2026 (AR2025; IR 1H2026). No dividends were paid FY2016 onward per filings reviewed for FY2019–FY2025.

Ratio analysis (analyst-computed from filed figures)

ROIC uses NOPAT (operating income ex other income multiplied by one minus the effective tax rate; statutory 15% applied in loss years) over year-end equity less net cash; because net cash consumes most of equity, invested capital is small (HK$11–26M in FY2023–FY2025) and ROIC is consequently very high and volatile — it is a measure of the operating business's capital-lightness rather than of shareholder returns. Net debt/EBITDA and interest coverage are not meaningful (no debt, no finance costs). The very long cash conversion cycle reflects project WIP held in inventory; it is largely funded by customer deposits (contract liabilities), which the standard CCC formula ignores.

Trend commentary. Returns on equity are depressed by the cash pile: the operating business earns high returns on the small capital it actually uses, but ~85% of equity is cash and deposits yielding 0%–2.9% (IR 1H2026 Note 13). The inflection points are FY2023 (volume-driven recovery), FY2025 (margin-driven peak) and 1H2026 (volume up, margin down).

Interim snapshot (1H2026 vs 1H2025)

Source: IR 1H2026. Trailing-twelve-month revenue to 30 June 2026 is HK$147.8M and TTM net profit HK$8.6M (analyst-computed: 2H2025 plus 1H2026).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityRoleSource

RENHENG Enterprise Holdings Limited (Cayman)

Listed holding company; investment holding and corporate management services

AR2025

RENHENG Global Limited

Intermediate holding company (named in equity reserve note)

Interim Report 2025

Bao Ying Ren Heng Industrial Co., Ltd (寶應仁恒實業有限公司)

Wholly owned PRC operating subsidiary; licensed tobacco machinery manufacturer; HNTE

AR2025 ESG; IR 1H2026

LinkBest Capital Group Ltd / Open Venture Global Ltd

Controlling shareholders (wholly owned by Ms. Liu Li)

AR2025

Product Lines

Product lineFY2021FY2022FY2023FY2024FY2025

Casing and flavouring systems (HKD Mn)

37.31655.551102.897108.72286.375

Pneumatic feeding systems (HKD Mn)

14.5449.93218.8033.50918.381

Pre-pressing packing machines (HKD Mn)

15.3980002.040

Water treatment systems (HKD Mn)

0.6920.7090.27100

Other goods (HKD Mn)

5.7812.8912.4522.6650.626

Total revenue (HKD Mn)

73.73169.083124.423114.896107.422

Product Lines — Casing and flavouring systems

Product lineFY2021FY2022FY2023FY2024FY2025

Casing and flavouring systems (% of revenue)

50.680.482.794.680.4

Pneumatic feeding systems (% of revenue)

19.714.415.13.117.1

Pre-pressing packing machines (% of revenue)

20.90001.9

Water treatment and other goods (% of revenue)

8.85.22.22.30.6

Product Lines — Casing and flavouring gross profit

Product lineFY2021FY2022FY2023FY2024FY2025

Casing and flavouring gross profit (HKD Mn)

15.38018.31335.28335.72841.320

Casing and flavouring gross margin (%)

41.233.034.332.947.8

Pneumatic feeding gross profit (HKD Mn)

6.7105.5319.1931.9719.148

Pneumatic feeding gross margin (%, analyst-computed)

46.155.748.956.249.8

Water treatment gross profit (HKD Mn)

0.3090.2800.12200

Group gross margin (%)

38.437.036.733.547.9

Product Lines (FY2022–FY2025)

Product lineFY2022FY2023FY2024FY2025

Casing and flavouring systems (YoY %)

48.985.25.7-20.6

Pneumatic feeding systems (YoY %)

-31.789.3-81.3423.8

Total revenue (YoY %)

-6.380.1-7.7-6.5

Results by Segment and Segment Margins & Growth (%)

MetricFY2021FY2022FY2023FY2024FY2025

Segment operating income (HKD Mn, analyst-computed)

-2.633-3.16714.5867.61712.466

Segment operating margin (%)

-3.6-4.611.76.611.6

Segment pre-tax income (HKD Mn)

3.368-0.58817.91810.33416.925

Segment pre-tax margin (%)

4.6-0.914.49.015.8

Revenue by Segment

MetricFY2021FY2022FY2023FY2024FY2025

Average contract sum completed (HKD Mn)

2.6652.2226.4314.7273.599

Revenue from three largest contracts (HKD Mn)

32.44133.13477.348—48.894

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Revenue by Segment (Half-Yearly)

MetricH1 2024H2 2024H1 2025H2 2025H1 2026

Revenue (HKD Mn)

60.97953.91760.64046.782100.977

Profit for the period (HKD Mn)

7.555-0.52013.0580.8977.685

Casing and flavouring revenue (HKD Mn)

——52.58233.79396.306

Pneumatic feeding revenue (HKD Mn)

——8.05810.3233.812

Income Statement and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Revenue (HKD Mn)

73.73169.083124.423114.896107.422

Cost of sales (HKD Mn)

45.45443.51678.69976.36956.001

Gross profit (HKD Mn)

28.27725.56745.72438.52751.421

Other income (HKD Mn)

2.7371.8581.5451.9133.079

Other gains and losses net (HKD Mn)

3.2640.7211.7870.8041.380

Credit loss charge (reversal) (HKD Mn)

0.160-0.042-0.3220.1140.594

Selling and distribution expenses (HKD Mn)

9.2127.79710.2106.45210.243

Administrative expenses (HKD Mn)

17.03016.65516.57819.73921.422

R&D expenses (HKD Mn)

4.5084.3244.6724.6056.696

Operating income ex other income (HKD Mn, analyst-computed)

-2.633-3.16714.5867.61712.466

Finance costs (HKD Mn)

00000

Profit before tax (HKD Mn)

3.368-0.58817.91810.33416.925

Taxation (HKD Mn)

2.6471.7754.3603.2992.970

Net profit attributable (HKD Mn)

0.721-2.36313.5587.03513.955

FX translation OCI (HKD Mn)

3.021-9.514-1.493-2.4102.856

Total comprehensive income (HKD Mn)

3.742-11.87712.0654.62516.811

Basic EPS (HK cents)

0.09-0.291.690.881.74

Diluted EPS (HK cents)

0.09-0.291.690.881.74

Dividend per share (HK cents)

00000

Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Gross margin (%)

38.437.036.733.547.9

Operating margin ex other income (%)

-3.6-4.611.76.611.6

Pre-tax margin (%)

4.6-0.914.49.015.8

Net margin (%)

1.0-3.410.96.113.0

Effective tax rate (%)

78.6-301.924.331.917.5

Selling expense ratio (%)

12.511.38.25.69.5

Administrative expense ratio (%)

23.124.113.317.219.9

Balance Sheet and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Property plant and equipment (HKD Mn)

7.64022.96721.06118.69717.788

Investment properties (HKD Mn)

21.8930000

Right-of-use assets (HKD Mn)

2.6805.1155.0214.6204.702

Inventories (HKD Mn)

76.28297.09772.55456.296105.373

Trade and other receivables (HKD Mn)

41.45230.98738.78049.38046.611

Of which trade-related receivables net (HKD Mn)

19.33817.02027.91243.76439.996

Financial assets at FVTPL (HKD Mn)

00021.5980

Restricted or pledged bank deposits (HKD Mn)

22.0115.08712.00119.84827.267

Fixed deposits (HKD Mn)

00015.50017.322

Cash and cash equivalents (HKD Mn)

96.04097.19586.10059.53278.951

Total assets (HKD Mn)

267.998258.448235.517245.471298.014

Trade and other payables (HKD Mn)

54.80847.59042.02429.30035.313

Warranty provision separately presented (HKD Mn)

0005.2064.800

Contract liabilities (HKD Mn)

80.10090.15357.82871.847100.225

Tax payable (HKD Mn)

7.7406.99510.3879.28011.249

Lease liabilities (HKD Mn)

0.30000.21200.205

Deferred tax liabilities (HKD Mn)

1.8522.3891.6801.8271.400

Short-term debt (HKD Mn)

00000

Long-term debt (HKD Mn)

00000

Total equity (HKD Mn)

123.198111.321123.386128.011144.822

Goodwill and intangibles (HKD Mn)

00000

Net current assets / working capital (HKD Mn)

92.83785.62898.984106.521123.732

Gross liquid funds incl. pledged fixed and FVTPL (HKD Mn, analyst-computed)

118.051102.28298.101116.478123.540

Net cash after leases (HKD Mn, analyst-computed)

117.751102.28297.889116.478123.335

Net cash per share (HK$, analyst-computed)

0.1460.1270.1220.1450.153

Cash Flow

MetricFY2021FY2022FY2023FY2024

Operating cash flow (HKD Mn; aggregator)

10.640-7.211-3.32319.978

Dividends paid (HKD Mn)

0000

Share buybacks (HKD Mn)

0000

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2021FY2022FY2023FY2024FY2025

ROE on average equity (%)

0.6-2.011.65.610.2

ROA on average total assets (%)

0.3-0.95.52.95.1

ROIC on year-end equity less net cash (%)

-9.0-35.043.345.147.8

Current ratio (x)

1.651.591.901.921.82

Quick ratio as reported by company (x)

1.10.91.21.41.1

Debt to equity (x)

00000

Asset turnover on average assets (x)

0.280.260.500.480.40

Days inventory on average balance (days)

613727393308527

Days sales outstanding, trade-related, average (days)

969666114142

Days payables, trade and bills, average (days)

351336144110143

Cash conversion cycle (days)

358487315312526

Balance Sheet and Margin Analysis (%)

MetricH1 2025H1 2026

Revenue (HKD Mn)

60.640100.977

Gross profit (HKD Mn)

27.57326.516

Gross margin (%)

45.526.3

Selling and distribution costs (HKD Mn)

2.3824.339

Administrative expenses (HKD Mn)

9.88211.534

R&D costs (HKD Mn)

2.0332.186

Profit before tax (HKD Mn)

15.5859.590

Profit for the period (HKD Mn)

13.0587.685

Basic EPS (HK cents)

1.620.96

Total staff costs (HKD Mn)

10.65812.206

Inventories at period end (HKD Mn)

—64.776

Contract liabilities at period end (HKD Mn)

—56.752

Total equity at period end (HKD Mn)

—157.276

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Revenue by Region and Revenue by Region (%)

RegionFY2021FY2022FY2023FY2024FY2025

PRC revenue (HKD Mn)

73.73169.083124.423114.896107.422

Outside PRC revenue (HKD Mn)

00000

PRC share of revenue (%)

100100100100100

PRC revenue growth (YoY %)

-3.3-6.380.1-7.7-6.5

Supplier Region Details

Supplier regionNumber of suppliers FY2025

Eastern China

807

Central China

48

Western China

45

North-eastern China

11

Others

35

Total

946

Valuation Snapshot

MetricValueBasis / source

Share price

approx. HK$0.20

TipRanks quote page (accessed 12 Oct 2026)

52-week range

HK$0.17 – HK$0.31

TipRanks

Shares in issue

804,000,000

IR 1H2026

Market capitalisation

approx. HK$161.6M (approx. US$20.7M)

TipRanks; USD at approx. 7.8 HKD peg

Net cash at 30 Jun 2026 (cash, fixed and pledged deposits less leases)

HK$104.9M

IR 1H2026, analyst-computed

Enterprise value

approx. HK$56.6M

Analyst-computed

P/E on FY2025 EPS

approx. 11.5x

HK$0.20 / HK$0.0174

P/E on TTM to Jun 2026

approx. 18.8x

TTM profit HK$8.6M

EV / TTM sales

approx. 0.38x

TTM revenue HK$147.8M

EV / FY2025 operating income (ex other income)

approx. 4.5x

Proxy for EV/EBITDA (EBITDA not disclosed)

P/B at 30 Jun 2026

approx. 1.03x

Equity HK$157.3M

Average daily volume (3 months)

approx. 202,000 shares (approx. HK$40,000)

TipRanks

Share Price & Returns

HorizonPerformanceSource

1 year

Approximately flat (market cap approx. HK$164.8M in late Aug 2025 versus approx. HK$161.6M now)

TipRanks article Aug 2025; TipRanks quote

Since GEM IPO (Nov 2011, HK$1.20 pre-subdivision = HK$0.30 adjusted)

Approx. −33% (excluding dividends)

GEM allotment announcement; ROIC.ai split data

Capital Markets

MetricFY2021FY2022FY2023FY2024FY2025

Dividend per share (HK cents)

00000

Dividends paid (HKD Mn)

00000

Capital Markets — Buyback authorisation used

ItemStatusSource

Buyback authorisation used

No repurchases FY2021–1H2026

AR2025; IR 1H2026

General issuance mandate

Sought at 2026 AGM

TipRanks summary

Moody's / S&P / Fitch ratings

Not rated

—

Debt maturity profile

No borrowings; lease liability HK$0.115M at 30 Jun 2026

IR 1H2026

Bills payable (trade finance, secured by pledged deposits)

HK$4.4M at 30 Jun 2026

IR 1H2026 Note 14

Analyst Conclusions

Management guidance

No numerical guidance. Management's qualitative outlook (IR 1H2026) is that the tobacco machinery industry will remain steady, that the monopoly customer provides a stable financial foundation, and that the Group will strengthen internal management, digitalise design and project management, and pursue contracts in more than one machinery industry or new technological fields. Consensus estimates: none (no analyst coverage).

Bull case

  1. Volume is strong and the balance sheet is a floor. 1H2026 revenue of HK$101.0M was 94% of FY2025's full-year revenue; with net cash of approx. HK$105M (approx. HK$0.13 per share) against a HK$0.20 share price, the market ascribes only about HK$57M of enterprise value to an operating business that earned HK$12.5M of operating income in FY2025.

  2. Margin compression may be partly cyclical. Casing GPM has ranged from 32.9% to 47.8% across FY2021–FY2025; 1H2026's 24.8% could reflect a cluster of aggressively priced bids rather than a permanent reset, and the higher-margin pneumatic line (approx. 50% GPM) could rebound from its depressed 1H2026 level.

  3. Optionality on capital return or diversification. The cash pile, positive operating ROIC and growing R&D budget (HK$6.7M in FY2025) give the controlling shareholder levers to raise returns via distributions or to launch non-tobacco automation products.

Bear case

  1. Structural price erosion. Management explicitly cites both competitor pricing and client budget cuts; if 1H2026 economics persist, a full-year operating margin in low single digits is plausible given the expense base of approx. HK$36–38M per year.

  2. Backlog and collections are weakening. Contract liabilities nearly halved to HK$56.8M in 1H2026 and WIP fell to HK$61.8M, while net trade receivables rose to HK$53.4M with almost all aged over 90 days — signalling slower 2H2026 revenue and cash conversion.

  3. Governance and liquidity discount is durable. A 74.6% controller who is also Chairman and CEO, no dividends for a decade per filings reviewed, average daily turnover of roughly HK$40,000, two executive-director departures in 20 months and recurring disclosure inconsistencies mean the cash may never be distributed to minorities.

Catalysts and monitorables (next 12 months)

MonitorableWhy it mattersTiming
FY2026 annual resultsFull-year margin outcome after 1H2026 compression; 2H2026 revenue given lower backlogBoard meeting expected around end-March 2027 (TipRanks shows 31 Mar 2027)
Casing and flavouring GPM trajectoryTests whether 24.8% is a trough or a new normFY2026 results
Contract liabilities and WIPOrder visibility for FY2027FY2026 balance sheet
Trade receivable collections and ECL chargesCash conversion and credit qualityFY2026 results
HNTE renewalTax rate 15% vs 25%During 2026–2027
First non-tobacco contract or product disclosureValidation of diversification strategyAny time
Capital-return decision (dividend/special distribution/buyback)Unlocks discount to net cashFY2026 results
Nomination committee composition (B.3.5 compliance)Governance remediationPromised further announcement
Further board changesStability of executive bench (board at five)Ongoing
RMB/HK$ exchange rateTranslation of RMB-denominated equity and cashOngoing

Analyst verdict

RENHENG is a small, licensed, debt-free supplier of customised primary-processing equipment to China's tobacco monopoly whose investment case rests almost entirely on the relationship between its cash and its controller. The operating business is real and capital-light: across FY2023–FY2025 it generated cumulative operating income of approx. HK$34.7M on minimal invested capital, and the regulatory licence protects it from new entrants. But the licence does not protect price, and the 1H2026 interim demonstrated how quickly margins can compress when provincial clients tighten budgets and the other licensed manufacturers bid aggressively — casing and flavouring gross margin fell by 21 percentage points year on year even as volumes surged.

FY2025's record 47.9% gross margin should therefore be regarded as a peak, not a run-rate. A normalised view — group gross margin in the mid-30s on revenue of HK$100–130M against an expense base approaching HK$38M — implies operating income in the high single-digit millions of HK dollars, and therefore an enterprise value multiple that looks undemanding at roughly five to seven times. The equity trades at about 1.0x book with roughly two-thirds of the market value backed by net cash.

The obstacle is governance and liquidity. Ms. Liu Li controls 74.6% and holds both the Chair and CEO roles; no dividend has been paid in the filings reviewed for FY2019–FY2025 despite consistent net cash above HK$95M; trading liquidity is negligible; disclosure contains avoidable inconsistencies; and the diversification strategy has been restated for years without visible revenue. Until the controller signals a willingness to share the cash — through a special dividend, buyback or privatisation offer — the discount is likely to persist.

Verdict: a statistically cheap, high-risk, illiquid special situation.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleAppointedAge (AR2025)BackgroundSource

Ms. Liu Li

Chairman, CEO, Executive Director; controlling shareholder (74.6%)

ED since 2 Feb 2011; Chairman and CEO since 4 May 2016

55

Director of Yanlord Industry Investment since Feb 2007; oversees Baoying Renheng since 2008; responsible for planning, strategy, treasury, HR and administration; bachelor's in sport management, Beijing Sport University (1992)

AR2025; Webb-site

Ms. Lew Lai Kuen

Executive Director

10 Jul 2024

62

Marketing manager at Yanlord Paper Limited from Aug 2003; earlier marketing officer at Oceancrete Limited (1986–2003) and clerk at Far East Polyfoam (1982–1985); professional diploma in logistics management (2005)

AR2025

Dr. Lam Lee G.

INED; Chairman of Audit Committee; member of Remuneration and Nomination Committees

30 Jun 2022

66

Solicitor of the High Court of Hong Kong; extensive multi-board INED career across HK, Singapore, Malaysia, Australia and London listings; holds degrees including MBA (Ottawa) and PhD (HKU); numerous public and chamber appointments

AR2025

Mr. Lam Chi Wing

INED; Chairman of Remuneration Committee; member of Audit and Nomination Committees

19 Jul 2023

46

Corporate management, strategy consulting and investment banking; BBA (HKU), MSc (PolyU), MBA (CUHK), EMPA (Tsinghua); INED of China Wantian (1854), Alco (328), Carry Wealth (643)

AR2025

Mr. Cheung Kwong Tat

INED; Chairman of Nomination Committee; member of Audit and Remuneration Committees

31 Oct 2025

58

Former founding regional managing partner of Western China at Deloitte China; served on Deloitte China Governance Board for over six years; HKICPA member since 1996; INED of Wonderful Sky Financial (1260), Nanshan Aluminium International (2610), Million Hope Industries (1897), Golden Leaf International (8549)

AR2025

Executive Leadership Team

NameRoleBackgroundSource

Mr. Liu Yang

Director and Vice General Manager, Baoying Renheng; heads sales and marketing

Over 25 years in sales; joined Baoying Renheng June 2004; brother of Ms. Liu Li; bachelor's in marketing, Changchun University of Science and Technology

AR2025

Mr. Chan Kit Yan

Group VP of Operations and Financial Controller; executive director and legal representative of Baoying Renheng

Joined 2022; oversees sales, technical, production, HR, purchasing and administration at Baoying Renheng; University of Birmingham; CPA Australia associate

AR2025

Mr. Tsang Chi Hon

Company Secretary (since May 2022)

HKICPA member; previously CFO of Zuoan Fashion (NYSE-listed); company secretary and financial controller of Micron (International) Group

AR2025

Governance Overview

AttributeStatus (AR2025; IR 1H2026)

Board size

5 (2 executive, 3 INEDs) following Mr. Wen Yuan's resignation on 20 Feb 2026

Independence

60% INEDs

Chair/CEO separation

Not separated — Ms. Liu Li holds both roles; disclosed deviation from CG Code C.2.1 every year

Committees

Audit, Remuneration, Nomination — each composed entirely of INEDs; no separate corporate governance committee (the Board performs that function)

Gender

Two female directors (both executive). The nomination committee has no female member; the Company disclosed non-compliance with CG Code B.3.5 in IR 1H2026 and says it is seeking a candidate

Meetings FY2025

Four board meetings attended by all serving directors; three audit committee meetings

Family relationships

Mr. Liu Yang (senior management) is Ms. Liu Li's brother; AR2025 nonetheless states that directors have no relationships with each other, which is accurate at board level

Connected transactions

None disclosed for FY2025

Competing interests

None disclosed

Board & Management Changes

DateChangeContextSource

19 Jul 2023

Mr. Kong Hing Ki (INED since 2011) resigns; Mr. Lam Chi Wing appointed

Refresh of long-tenured INED

RA2023

10 Jul 2024

Mr. Xu Jiagui resigns as ED (other business commitments); Ms. Lew Lai Kuen appointed

Loss of the director with the longest operating tenure at Baoying Renheng (since 2002)

TipRanks summary; Webb-site

6 Dec 2024

Mr. Wen Yuan appointed ED

Background in pharmaceutical-sector management (Sinopharm, China Pharmaceutical Culture Society)

HKEX announcement 6 Dec 2024

31 Oct 2025

Mr. Wu Wei resigns as INED; Mr. Cheung Kwong Tat appointed

Adds Big Four audit-leadership experience

HKEX announcement 31 Oct 2025

20 Feb 2026

Mr. Wen Yuan resigns as ED after approx. 14 months

—

AR2025

Major Shareholders

HolderShares% of issuedNatureSource

LinkBest Capital Group Limited (100% Ms. Liu Li)

360,000,00044.8

Beneficial owner

IR 1H2026

Open Venture Global Limited (100% Ms. Liu Li)

240,000,00029.9

Beneficial owner

IR 1H2026

Ms. Liu Li (aggregate, via controlled corporations)

600,000,00074.6

Insider

IR 1H2026

Public float

204,000,00025.4

Analyst-computed residual

—

Competitive Landscape

Key Competitors

#CompetitorOwnership / listingOverlap with RENHENGRevenueRelative positioning
1

China Tobacco Machinery Group (中國煙草機械集團) and subsidiaries

State-owned, unlisted

Full range of primary and secondary processing equipment

—

System integrator and dominant state supplier; also a RENHENG customer/award-giver

2

Qinhuangdao Tobacco Machinery Co., Ltd.

Controlled by China Tobacco Machinery Group

Primary processing lines

—

Larger line integrator; simultaneously customer (supplier award) and competitor

3

Shanghai Tobacco Machinery Co., Ltd.

State tobacco system, unlisted

Primary processing and cigarette-making machinery

—

Major state-system supplier

4

Changde Tobacco Machinery Co., Ltd.

State tobacco system, unlisted

Cigarette making and processing equipment

—

Major state-system supplier

5

Xuchang Tobacco Machinery Co., Ltd.

State tobacco system, unlisted

Cigarette making and processing equipment

—

Major state-system supplier

6

KSEC Intelligent Technology (Kunming Shipbuilding Equipment)

State-owned, unlisted

Primary processing lines, logistics automation

—

Large primary-processing line integrator

7

Other licensed private manufacturers (approx. 30 of the 35 licensees)

Mostly private, unlisted

Specialised sub-systems (casing, flavouring, conveying, dedusting)

—

Direct bid competitors on sub-system tenders; source of 2026 price competition

8

Hauni Maschinenbau (Körber Group, Germany)

Private (Körber)

Primary processing and cigarette-making technology

Segment revenue not publicly disclosed

Global technology leader; limited direct presence via licensing and JVs

9

G.D S.p.A. (Coesia Group, Italy)

Private (Coesia)

Primarily secondary processing (making and packing)

Segment revenue not publicly disclosed

Indirect competitor

10

Garbuio Dickinson (Italy)

Private

Primary processing, redrying and leaf-threshing equipment

—

Competes in redrying/primary processing internationally

11

Comas S.p.A. (Italy)

Private

Primary processing and flavouring systems

—

Overlaps in casing and flavouring technology internationally

“—” = not publicly disclosed.

Competitor Detail

Metric (FY2025)RENHENG

Revenue

HK$107.4M

Revenue growth

-6.5%

Gross margin

47.9%

Operating margin (ex other income)

11.6%

R&D intensity

6.2%

Recent Developments

No contract-win announcements, litigation, regulatory sanctions, layoffs or guidance revisions (other than the profit warning) were identified.

Company Snapshot

$13.8M

Revenue

138

Employees

2002

Founded

Admiralty, Hong Kong

Headquarters

SWOT Analysis

Strengths

  • Regulatory licence restricting entry: One of 35 licensed manufacturers under the State Tobacco Monopoly Administration licence (AR2025)
  • Debt-free, cash-rich balance sheet: Zero bank borrowings FY2021–1H2026; net cash HK$123.3M at end-2025 (RA2025)
  • High-margin pneumatic feeding line: Gross margins of approx. 46%–56% annually FY2021–FY2025 (RA2022–RA2025)
  • Customer prepayment model funds working capital: 10%–30% deposits; contract liabilities HK$100.2M at end-2025 versus inventories HK$105.4M (RA2025)
  • Proven ability to scale volume with existing plant: 1H2026 revenue of HK$101.0M, nearly FY2025's full-year total, with headcount broadly flat (IR 1H2026; AR2025)
  • Preferential tax status: HNTE 15% rate since 2020, renewed (RA2022; RA2025)
  • State-system supplier credentials: "Excellent Supplier" award from Qinhuangdao Tobacco Machinery, 2022 and 2023 (RA2023)

Weaknesses

  • Extreme customer concentration: Top five customers 75.7% of FY2025 sales; largest 32.5% (AR2025)
  • Single product dependence: Casing and flavouring systems 80.4% of FY2025 revenue; 95.4% in 1H2026 (RA2025; IR 1H2026)
  • Earnings volatility and lumpy recognition: Net profit ranged from −HK$2.4M (FY2022) to +HK$14.0M (FY2025); 2H2024 loss of HK$0.5M (analyst-derived)
  • Deteriorating receivables ageing: HK$51.6M of HK$53.4M net trade receivables aged over 90 days at 30 Jun 2026 (IR 1H2026)
  • Concentrated governance: Combined Chairman/CEO; controlling shareholder 74.6%; CG Code B.3.5 non-compliance (IR 1H2026)
  • Low capital efficiency at equity level: ROE 5.6%–11.6% in profitable years, despite high operating ROIC, because ~85% of equity is cash (analyst-computed)
  • Disclosure quality issues: Contract statistics differ between RA2025 and AR2025; ESG workforce gender data inconsistent between sections

Opportunities

  • Diversification into non-tobacco customised automation: Stated strategy; R&D +45.4% in FY2025 aimed at new product lines in other industries (RA2025)
  • Energy-efficient product demand: Management targets 10%–15% revenue share from related new products within three years (AR2025 ESG)
  • Capital return potential: Net cash of HK$0.153 per share at end-2025 versus share price of approx. HK$0.20 (analyst-computed)
  • Volume momentum: 1H2026 casing revenue +83.2% YoY to HK$96.3M (IR 1H2026)
  • Revival of pre-pressing packing machines: HK$15.4M of revenue in FY2021; reappeared with HK$2.0M in FY2025 and re-listed as a principal product (RA2022; IR 1H2026)
  • Operating-cost savings from digitalisation: Management expects 1%–2% annual operating-cost savings over three years (AR2025 ESG)

Threats

  • Tender price compression: Casing GPM down from 45.8% to 24.8% (1H2025 to 1H2026) on bidder competition and client budget cuts (IR 1H2026)
  • Policy and budget risk at a single monopsony buyer: Revenue 100% PRC tobacco industry (RA2025)
  • Backlog depletion: Contract liabilities fell from HK$100.2M to HK$56.8M in 1H2026 (IR 1H2026)
  • Expense creep: FY2025 selling +58.8%, admin +8.5%, R&D +45.4% while revenue fell 6.5% (RA2025)
  • HNTE renewal risk: Status stated to expire in 2026 (RA2025); loss would raise the rate from 15% to 25%
  • Currency translation: FY2022 OCI of −HK$9.5M from RMB depreciation (RA2022)
  • Physical climate risk concentration: Management acknowledges vulnerability due to geographic concentration of assets in one site (AR2025 ESG Part D)

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
Apr 2025FY2024 annual report published; AGM circular dated 29 Apr 2025 AGM poll results 25 Jun 2025FY2024 profit HK$7.0M, GPM 33.5%
25 Jun 2025AGM — all resolutions passed, including re-election of Ms. Lew Lai Kuen and Mr. Wen Yuan as executive directors and auditor reappointment HKEX poll results 25 Jun 2025Routine; controlling shareholder ensures passage
Aug 2025Board meeting notice for interim results (meeting 29 Aug 2025) TipRanks summaryRoutine
29 Aug 20251H2025 results: revenue −0.6% to HK$60.6M; profit +72.8% to HK$13.1M; no interim dividend IR 1H2025Margin-driven profit surge
26 Sep 20252025 Interim Report published HKEXnewsRoutine
31 Oct 2025INED Mr. Wu Wei resigns; Mr. Cheung Kwong Tat appointed INED and Nomination Committee chair HKEX announcementStrengthens audit expertise
20 Feb 2026Executive director Mr. Wen Yuan resigns AR2025; TipRanks summaryBoard shrinks to five; second ED departure in 20 months
9 Mar 2026Notice of board meeting on 30 Mar 2026 for FY2025 results HKEX announcementRoutine
Mar 2026Positive profit alert citing stronger margins and pneumatic system sales TipRanks summary of HKEX announcementPre-announces FY2025 profit growth
Mar 2026Proposal to adopt new articles permitting hybrid meetings and paperless communications TipRanks summaryGovernance modernisation
30 Mar 2026FY2025 annual results: revenue HK$107.4M (−6.5%), profit HK$14.0M (+98.4%), GPM 47.9%; no final dividend RA2025Record margin; no distribution despite net cash
28 Apr 2026FY2025 Annual Report published, including expanded climate (Part D) disclosures AR2025Introduces climate risk/opportunity quantification; discrepancies vs RA2025 on contract statistics
Apr–May 20262026 AGM notice issued, including general share-issuance mandate TipRanks summaryPotential dilution authority
25 Jun 2026AGM — all resolutions passed, including re-election of Ms. Liu Li, Mr. Lam Chi Wing and Mr. Cheung Kwong Tat, and governance changes TipRanks summary; AR2025Routine
10 Aug 2026Notice of board meeting on 27 Aug 2026 for interim results HKEX announcementRoutine
19 Aug 2026Profit warning: 1H2026 profit expected to fall versus approx. HK$13.1M in 1H2025, citing pricing pressure on core products HKEX profit warningFirst negative alert since FY2022 loss
27 Aug 20261H2026 results: revenue +66.5% to HK$101.0M; profit −41.1% to HK$7.7M; GPM 26.3%; casing GPM 24.8% vs 45.8% IR 1H2026Bid-price compression confirmed; volume strong
27 Aug 2026Disclosure of non-compliance with CG Code B.3.5 (no different-gender member on nomination committee) IR 1H2026Governance gap to be remedied
27 Aug 2026Contract liabilities fall to HK$56.8M (from HK$100.2M) and WIP inventory to HK$61.8M (from HK$102.7M) as backlog converts to revenue IR 1H2026Order book visibility for 2H2026 reduced
27 Aug 2026Net trade receivables rise to HK$53.4M, with HK$51.6M aged over 90 days from completion IR 1H2026 Note 12Collection risk monitorable
Sep 2026 (expected)Routine

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

8 charts
Income Statement: Revenue & Gross Profit: Revenue rose from HKD 73.7 Mn in FY2021 to HKD 107.4 Mn in FY2025.
RENHENG Enterprise Holdings Limited — Income Statement: Revenue & Gross Profit
Series (HKD Mn)FY2021FY2022FY2023FY2024FY2025
Revenue73.769.1124.4114.9107.4
Cost of sales45.543.578.776.456
Gross profit28.325.645.738.551.4

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.